The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer

Cell

Volumn 149, Issue 3, 2012, Pages 642-655

  Kumar, Madhu S ^a   Hancock, David C ^a   Molina Arcas, Miriam ^a   Steckel, Michael ^a   East, Phillip ^a   Diefenbacher, Markus ^a   Armenteros Monterroso, Elena ^a   Lassailly, François ^a   Matthews, Nik ^a   Nye, Emma ^a   Stamp, Gordon ^a   Behrens, Axel ^a   Downward, Julian ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 2; PROTEASOME; RHO FACTOR; TAMOXIFEN; TRANSCRIPTION FACTOR GATA 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; CELL MUTANT; CELL VIABILITY; CONTROLLED STUDY; ENZYME REGULATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE REPRESSION; GENETIC ANALYSIS; GENOME; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; ONCOGENE K RAS; ONCOGENE RAS; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84860319361     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2012.02.059     Document Type: Article

References (68)

1. D.A. Barbie, P. Tamayo, J.S. Boehm, S.Y. Kim, S.E. Moody, I.F. Dunn, A.C. Schinzel, P. Sandy, E. Meylan, and C. Scholl Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 Nature 462 2009 108 112
2. R.B. Blasco, S. Francoz, D. Santamaría, M. Cañamero, P. Dubus, J. Charron, M. Baccarini, and M. Barbacid c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma Cancer Cell 19 2011 652 663
3. Z. Cao, J. Xiong, M. Takeuchi, T. Kurama, and D.V. Goeddel TRAF6 is a signal transducer for interleukin-1 Nature 383 1996 443 446 (Pubitemid 26330834)
4. M.A. Charles, T.L. Saunders, W.M. Wood, K. Owens, A.F. Parlow, S.A. Camper, E.C. Ridgway, and D.F. Gordon Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function Mol. Endocrinol. 20 2006 1366 1377 (Pubitemid 43801237)
5. Y. Chien, S. Kim, R. Bumeister, Y.M. Loo, S.W. Kwon, C.L. Johnson, M.G. Balakireva, Y. Romeo, L. Kopelovich, and M. Gale Jr. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival Cell 127 2006 157 170 (Pubitemid 44472624)
6. D.R. Croft, E. Sahai, G. Mavria, S. Li, J. Tsai, W.M. Lee, C.J. Marshall, and M.F. Olson Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis Cancer Res. 64 2004 8994 9001 (Pubitemid 39665509)
7. J.E. Darnell Jr. Transcription factors as targets for cancer therapy Nat. Rev. Cancer 2 2002 740 749 (Pubitemid 37328909)
8. C.A. Dinarello Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev. 29 2010 317 329
9. L. Ding, G. Getz, D.A. Wheeler, E.R. Mardis, M.D. McLellan, K. Cibulskis, C. Sougnez, H. Greulich, D.M. Muzny, and M.B. Morgan Somatic mutations affect key pathways in lung adenocarcinoma Nature 455 2008 1069 1075
10. J.A. Engelman, L. Chen, X. Tan, K. Crosby, A.R. Guimaraes, R. Upadhyay, M. Maira, K. McNamara, S.A. Perera, and Y. Song Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers Nat. Med. 14 2008 1351 1356
11. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2893 2917
12. D. Hameyer, A. Loonstra, L. Eshkind, S. Schmitt, C. Antunes, A. Groen, E. Bindels, J. Jonkers, P. Krimpenfort, and R. Meuwissen Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues Physiol. Genomics 31 2007 32 41 (Pubitemid 47443846)
13. L. Hennighausen, and G.W. Robinson Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B Genes Dev. 22 2008 711 721 (Pubitemid 351439101)
14. E.L. Jackson, N. Willis, K. Mercer, R.T. Bronson, D. Crowley, R. Montoya, T. Jacks, and D.A. Tuveson Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras Genes Dev. 15 2001 3243 3248 (Pubitemid 34008190)
15. L. Johnson, K. Mercer, D. Greenbaum, R.T. Bronson, D. Crowley, D.A. Tuveson, and T. Jacks Somatic activation of the K-ras oncogene causes early onset lung cancer in mice Nature 410 2001 1111 1116 (Pubitemid 32391044)
16. Y. Kanki, T. Kohro, S. Jiang, S. Tsutsumi, I. Mimura, J. Suehiro, Y. Wada, Y. Ohta, S. Ihara, and H. Iwanari Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression EMBO J. 30 2011 2582 2595
17. B.H. Lee, M.J. Lee, S. Park, D.C. Oh, S. Elsasser, P.C. Chen, C. Gartner, N. Dimova, J. Hanna, and S.P. Gygi Enhancement of proteasome activity by a small-molecule inhibitor of USP14 Nature 467 2010 179 184
18. A.K. Linnemann, H. O'Geen, S. Keles, P.J. Farnham, and E.H. Bresnick Genetic framework for GATA factor function in vascular biology Proc. Natl. Acad. Sci. USA 108 2011 13641 13646
19. J. Luo, M.J. Emanuele, D. Li, C.J. Creighton, M.R. Schlabach, T.F. Westbrook, K.K. Wong, and S.J. Elledge A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene Cell 137 2009 835 848
20. E. Meylan, A.L. Dooley, D.M. Feldser, L. Shen, E. Turk, C. Ouyang, and T. Jacks Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma Nature 462 2009 104 107
21. J.C. Montero, S. Seoane, A. Ocaña, and A. Pandiella Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors Clin. Cancer Res. 17 2011 5546 5552
22. L.A. O'Neill The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress Immunol. Rev. 226 2008 10 18
23. M.F. Olson, H.F. Paterson, and C.J. Marshall Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 Nature 394 1998 295 299 (Pubitemid 28335044)
24. R. Perona, S. Montaner, L. Saniger, I. Sánchez-Pérez, R. Bravo, and J.C. Lacal Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins Genes Dev. 11 1997 463 475 (Pubitemid 27097645)
25. M.E. Pitulescu, and R.H. Adams Eph/ephrin molecules - a hub for signaling and endocytosis Genes Dev. 24 2010 2480 2492
26. M. Puyol, A. Martín, P. Dubus, F. Mulero, P. Pizcueta, G. Khan, C. Guerra, D. Santamaría, and M. Barbacid A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma Cancer Cell 18 2010 63 73
27. S.K. Radhakrishnan, C.S. Lee, P. Young, A. Beskow, J.Y. Chan, and R.J. Deshaies Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells Mol. Cell 38 2010 17 28
28. V. Sanz-Moreno, C. Gaggioli, M. Yeo, J. Albrengues, F. Wallberg, A. Viros, S. Hooper, R. Mitter, C.C. Féral, and M. Cook ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma Cancer Cell 20 2011 229 245
29. D. Schmidt, M.D. Wilson, C. Spyrou, G.D. Brown, J. Hadfield, and D.T. Odom ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions Methods 48 2009 240 248
30. L. Soucek, J. Whitfield, C.P. Martins, A.J. Finch, D.J. Murphy, N.M. Sodir, A.N. Karnezis, L.B. Swigart, S. Nasi, and G.I. Evan Modelling Myc inhibition as a cancer therapy Nature 455 2008 679 683
31. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 2005 15545 15550 (Pubitemid 41528093)
32. D.A. Tuveson, A.T. Shaw, N.A. Willis, D.P. Silver, E.L. Jackson, S. Chang, K.L. Mercer, R. Grochow, H. Hock, and D. Crowley Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects Cancer Cell 5 2004 375 387 (Pubitemid 38482073)
33. A. Valouev, D.S. Johnson, A. Sundquist, C. Medina, E. Anton, S. Batzoglou, R.M. Myers, and A. Sidow Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data Nat. Methods 5 2008 829 834
34. S. Vicent, R. Chen, L.C. Sayles, C. Lin, R.G. Walker, A.K. Gillespie, A. Subramanian, G. Hinkle, X. Yang, and S. Saif Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models J. Clin. Invest. 120 2010 3940 3952
35. W. Xue, E. Meylan, T.G. Oliver, D.M. Feldser, M.M. Winslow, R.T. Bronson, and T. Jacks Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma Cancer Discov 1 2011 236 247
36. S. Yamaoka, G. Courtois, C. Bessia, S.T. Whiteside, R. Weil, F. Agou, H.E. Kirk, R.J. Kay, and A. Israël Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation Cell 93 1998 1231 1240 (Pubitemid 28307427)
37. Bailey, T.L.; and Elkan, C. (1994). Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2, 28-36.
38. Blasco, R.B.; Francoz, S.; Santamaría, D.; Cañamero, M.; Dubus, P.; Charron, J.; Baccarini, M.; and Barbacid, M. (2011). c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. Cancer Cell 19, 652-663.
39. Böhm, M.; Locke, W.J.; Sutherland, R.L.; Kench, J.G.; and Henshall, S.M. (2009). A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene 28, 3847-3856.
40. Charles, M.A.; Saunders, T.L.; Wood, W.M.; Owens, K.; Parlow, A.F.; Camper, S.A.; Ridgway, E.C.; and Gordon, D.F. (2006). Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol. Endocrinol. 20, 1366-1377. (Pubitemid 43801237)
41. Croft, D.R.; Sahai, E.; Mavria, G.; Li, S.; Tsai, J.; Lee, W.M.; Marshall, C.J.; and Olson, M.F. (2004). Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res. 64, 8994-9001. (Pubitemid 39665509)
42. De Raedt, T.; Walton, Z.; Yecies, J.L.; Li, D.; Chen, Y.; Malone, C.F.; Maertens, O.; Jeong, S.M.; Bronson, R.T.; Lebleu, V.; et al. (2011). Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell 20, 400-413.
43. DuPage, M.; Dooley, A.L.; and Jacks, T. (2009). Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protoc. 4, 1064-1072.
44. Fujiwara, T.; O'Geen, H.; Keles, S.; Blahnik, K.; Linnemann, A.K.; Kang, Y.A.; Choi, K.; Farnham, P.J.; and Bresnick, E.H. (2009). Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 36, 667-681.
45. Gentleman, R.C.; Carey, V.J.; Bates, D.M.; Bolstad, B.; Dettling, M.; Dudoit, S.; Ellis, B.; Gautier, L.; Ge, Y.; Gentry, J.; et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80.
46. González-García, A.; Pritchard, C.A.; Paterson, H.F.; Mavria, G.; Stamp, G.; and Marshall, C.J. (2005). RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7, 219-226. (Pubitemid 40568681)
47. Gupta, S.; Ramjaun, A.R.; Haiko, P.; Wang, Y.; Warne, P.H.; Nicke, B.; Nye, E.; Stamp, G.; Alitalo, K.; and Downward, J. (2007). Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell 129, 957-968. (Pubitemid 46802703)
48. Hahn, C.N.; Chong, C.E.; Carmichael, C.L.; Wilkins, E.J.; Brautigan, P.J.; Li, X.C.; Babic, M.; Lin, M.; Carmagnac, A.; Lee, Y.K.; et al. (2011). Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43, 1012-1017.
49. Hameyer, D.; Loonstra, A.; Eshkind, L.; Schmitt, S.; Antunes, C.; Groen, A.; Bindels, E.; Jonkers, J.; Krimpenfort, P.; Meuwissen, R.; et al. (2007). Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol. Genomics 31, 32-41. (Pubitemid 47443846)
50. Ianari, A.; Natale, T.; Calo, E.; Ferretti, E.; Alesse, E.; Screpanti, I.; Haigis, K.; Gulino, A.; and Lees, J.A. (2009). Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell 15, 184-194.
51. Johnson, L.; Mercer, K.; Greenbaum, D.; Bronson, R.T.; Crowley, D.; Tuveson, D.A.; and Jacks, T. (2001). Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116. (Pubitemid 32391044)
52. Kanki, Y.; Kohro, T.; Jiang, S.; Tsutsumi, S.; Mimura, I.; Suehiro, J.; Wada, Y.; Ohta, Y.; Ihara, S.; Iwanari, H.; et al. (2011). Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression. EMBO J. 30, 2582-2595.
53. Karreth, F.A.; Frese, K.K.; Denicola, G.M.; Baccarini, M.; and Tuveson, D.A. (2011). C-Raf is required for the initiation of lung cancer by K-Ras. Cancer Discov 1, 128-136.
54. Lee, B.H.; Lee, M.J.; Park, S.; Oh, D.C.; Elsasser, S.; Chen, P.C.; Gartner, C.; Dimova, N.; Hanna, J.; Gygi, S.P.; et al. (2010). Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179-184.
55. Li, H.; and Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760.
56. Linnemann, A.K.; O'Geen, H.; Keles, S.; Farnham, P.J.; and Bresnick, E.H. (2011). Genetic framework for GATA factor function in vascular biology. Proc. Natl. Acad. Sci. USA 108, 13641-13646.
57. Ostergaard, P.; Simpson, M.A.; Connell, F.C.; Steward, C.G.; Brice, G.; Woollard, W.J.; Dafou, D.; Kilo, T.; Smithson, S.; Lunt, P.; et al. (2011). Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 43, 929-931.
58. Radhakrishnan, S.K.; Lee, C.S.; Young, P.; Beskow, A.; Chan, J.Y.; and Deshaies, R.J. (2010). Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol. Cell 38, 17-28.
59. Sahai, E.; Ishizaki, T.; Narumiya, S.; and Treisman, R. (1999). Transformation mediated by RhoA requires activity of ROCK kinases. Curr. Biol. 9, 136-145. (Pubitemid 29087543)
60. Santos, S.C.; Lacronique, V.; Bouchaert, I.; Monni, R.; Bernard, O.; Gisselbrecht, S.; and Gouilleux, F. (2001). Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. Oncogene 20, 2080-2090. (Pubitemid 32424002)
61. Subramanian, A.; Tamayo, P.; Mootha, V.K.; Mukherjee, S.; Ebert, B.L.; Gillette, M.A.; Paulovich, A.; Pomeroy, S.L.; Golub, T.R.; Lander, E.S.; and Mesirov, J.P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550. (Pubitemid 41528093)
62. Tijssen, M.R.; Cvejic, A.; Joshi, A.; Hannah, R.L.; Ferreira, R.; Forrai, A.; Bellissimo, D.C.; Oram, S.H.; Smethurst, P.A.; Wilson, N.K.; et al. (2011). Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev. Cell 20, 597-609.
63. Tong, Q.; Dalgin, G.; Xu, H.; Ting, C.N.; Leiden, J.M.; and Hotamisligil, G.S. (2000). Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290, 134-138.
64. Torres, J.; and Watt, F.M. (2008). Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3. Nat. Cell Biol. 10, 194-201. (Pubitemid 351194049)
65. Tsai, F.Y.; Keller, G.; Kuo, F.C.; Weiss, M.; Chen, J.; Rosenblatt, M.; Alt, F.W.; and Orkin, S.H. (1994). An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221-226. (Pubitemid 24293019)
66. Tuveson, D.A.; Shaw, A.T.; Willis, N.A.; Silver, D.P.; Jackson, E.L.; Chang, S.; Mercer, K.L.; Grochow, R.; Hock, H.; Crowley, D.; et al. (2004). Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375-387. (Pubitemid 38482073)
67. Zhang, S.J.; Ma, L.Y.; Huang, Q.H.; Li, G.; Gu, B.W.; Gao, X.D.; Shi, J.Y.; Wang, Y.Y.; Gao, L.; Cai, X.; et al. (2008a). Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc. Natl. Acad. Sci. USA 105, 2076-2081. (Pubitemid 351439467)
68. Zhang, Y.; Liu, T.; Meyer, C.A.; Eeckhoute, J.; Johnson, D.S.; Bernstein, B.E.; Nusbaum, C.; Myers, R.M.; Brown, M.; Li, W.; and Liu, X.S. (2008b). Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137.